Your browser doesn't support javascript.
loading
Robotic versus open extended cholecystectomy for T1a-T3 gallbladder cancer: A matched comparison.
Yang, Jun; Li, Enliang; Wang, Cong; Luo, Shuaiwu; Fu, Zixuan; Peng, Jiandong; Liao, Wenjun; Wu, Linquan.
Afiliação
  • Yang J; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li E; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wang C; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Luo S; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Fu Z; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Peng J; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liao W; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wu L; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Front Surg ; 9: 1039828, 2022.
Article em En | MEDLINE | ID: mdl-36420415
ABSTRACT

Background:

The feasibility and safety of robotic extended cholecystectomy (REC) are still uncertain. This study was performed to compare the short- and long-term outcomes of REC with those of open extended cholecystectomy (OEC) for T1a-T3 gallbladder cancer.

Methods:

From January 2015 to April 2022, 28 patients underwent REC in our center. To minimize any confounding factors, a 12 propensity score-matching analysis was conducted based on the patients' demographics, liver function indicators, T stage, and symptoms. The data regarding demographics, perioperative outcomes, and long-term oncologic outcomes were reviewed.

Results:

The visual analogue scale score was significantly lower in the REC than OEC group immediately postoperatively (3.68 ± 2.09 vs. 4.73 ± 1.85, P = 0.008), on postoperative day 1 (2.96 ± 1.75 vs. 3.69 ± 1.41, P = 0.023), and on postoperative day 2 (2.36 ± 1.55 vs. 2.92 ± 1.21, P = 0.031). In addition, the REC group exhibited a shorter time to first ambulation (P = 0.043), a shorter time to drainage tube removal (P = 0.038), and a shorter postoperative stay (P = 0.037), but hospital costs were significantly higher in the REC group (P < 0.001). However, no statistically significant difference was found in the operation time (P = 0.134), intraoperative blood loss (P = 0.467), or incidence of postoperative morbidity (P = 0.227) or mortality (P = 0.289) between the REC and OEC groups. In regard to long-term outcomes, the 3-year disease-free survival rate was comparable between the OEC and REC groups (43.1% vs. 57.2%, P = 0.684), as was the 3-year overall survival rate (62.8% vs. 75.0%, P = 0.619).

Conclusion:

REC can be an effective and safe alternative to OEC for selected patients with T1a-T3 gallbladder cancer with respect to short- and long-term outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China